Lebanon's health ministry. It regulates medicines, runs the national cancer registry, pays for hospital care and selected high-cost medicines for uninsured Lebanese, and in 2026 made mammography free all year in government hospitals.
The Ministry of Public Health combines stewardship and regulation of the health sector with paying for and providing care for uninsured Lebanese: its October 2026 Health System Assessment describes it as insurer of last resort for eligible uninsured Lebanese, financing medicines, hospitalisation and, most recently, primary care. Medicines are registered by its Technical Committee for drug registration, which under Decree No. 571 treats the US FDA, the EMA and authorities aligned with WHO recommendations as reference authorities. Law No. 253/2022 created a Lebanese Drug Agency as an independent regulator; in November 2026 the Minister said the agency's appointments would be made soon with the Civil Service Council. The coordinates on this record are an approximate Beirut point.
Its Catastrophic Disease Management Program supplies selected high-cost medicines under strict eligibility; in 2024 cancer patients were its largest group of beneficiaries, 5,865 people, and the list of the program's medicines the Ministry posted in October 2024 has 105 entries under antineoplastic drugs, among them pembrolizumab, nivolumab, palbociclib and trastuzumab. The Assessment records that the crisis widened the program to patients from nearly every insurance scheme, which it says puts its sustainability in question.
The Ministry runs the National Cancer Registry, whose tables for 2005 to 2024 are on its website. Its National Cancer Program, formalised at cabinet level, oversees the National Cancer Plan 2023 to 2028. In October 2026 it made digital mammography free all year for Lebanese women over 40 in every government hospital, and in November 2026 it launched a prostate screening campaign paying for a PSA test, and an MRI if needed, for men aged 50 to 70.
Shows in one hospital how withdrawing public subsidy for immunotherapy in October 2022 turned access into a question of who could pay.
A new cancer medicine approved abroad since 2020 is unlikely to be registered in Lebanon, so patients and doctors depend on older medicines, generics, biosimilars or imports outside the registered market.
Describes, from patients, what the medicine shortage of 2021 and 2022 meant: interrupted treatment and insurance that no longer paid.
Shows cervical screening can be delivered through public primary care in Lebanon, where screening has been opportunistic and paid for privately.
Puts a number on how the cost of a common Lebanese cancer moved from insurers to households after 2019.
Shares Arafat Tfayli, American University of Beirut Medical Center / Naef K. Basile Cancer Institute.
Shares World Health Organization Cancer Programme, Global oncology and access in low- and middle-income countries, International Agency for Research on Cancer (IARC / WHO), Childhood cancers (all types).
Shares World Health Organization Cancer Programme, Global oncology and access in low- and middle-income countries, International Agency for Research on Cancer (IARC / WHO), Childhood cancers (all types).
Shares World Health Organization Cancer Programme, Global oncology and access in low- and middle-income countries, International Agency for Research on Cancer (IARC / WHO), Childhood cancers (all types).
Shares American University of Beirut Medical Center / Naef K. Basile Cancer Institute, Breast cancer (all types).
Shares World Health Organization Cancer Programme, Global oncology and access in low- and middle-income countries, International Agency for Research on Cancer (IARC / WHO), Childhood cancers (all types).
Shares World Health Organization Cancer Programme, Global oncology and access in low- and middle-income countries, International Agency for Research on Cancer (IARC / WHO), Childhood cancers (all types).
Shares National Cancer Registry, Lebanon, Breast cancer (all types).
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/